• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

P-糖蛋白和多药耐药相关蛋白限制了小鼠体内沙奎那韦的脑摄取。

P-glycoprotein and mutlidrug resistance-associated proteins limit the brain uptake of saquinavir in mice.

作者信息

Park Seonghee, Sinko Patrick J

机构信息

Rutgers University, Ernest Mario School of Pharmacy, 160 Frelinghuysen Rd., Piscataway, NJ 08854, USA.

出版信息

J Pharmacol Exp Ther. 2005 Mar;312(3):1249-56. doi: 10.1124/jpet.104.076216. Epub 2004 Nov 4.

DOI:10.1124/jpet.104.076216
PMID:15528451
Abstract

Efflux transporters such as P-glycoprotein (P-gp) and multidrug resistance-associated proteins (Mrps) and their contributions to saquinavir (SQV) brain uptake were characterized. Cerebral flow rate was estimated from diazepam uptake and brain vascular volume was assessed using inulin. Mice brains were perfused with buffer containing SQV alone or coperfused with different concentrations of GF120918, a P-gp inhibitor or MK571, a specific Mrp family inhibitor. Inulin, a nonabsorbable marker, was also coperfused in all studies to assess whether the inhibitors altered the physical integrity of the blood-brain barrier (BBB). The estimated cerebral flow rate using diazepam was 250 ml.100g(-1.)min(-1). The brain vascular volume, estimated using inulin, was almost constant (0.94 +/- 0.03 ml.100 g(-1), n = 12) during the perfusion study. SQV uptake kinetics was linear during the sampling period. Inclusion of 10 muM GF120918 in the perfusate resulted in a more than 7-fold increase in the brain distributional volume (i.e., uptake) of SQV. Inclusion of 100 muM MK571 in the perfusate increased SQV apparent brain uptake by more than 4.4-fold, suggesting, for the first time, that Mrp transporters may play an important role in the brain uptake and retention of SQV. Neither GF120918 nor MK571 altered the integrity of the BBB during the time course of the study. Although the current results reaffirm that SQV is a P-gp substrate, this is the first report implicating the Mrp transporter family in the limited brain uptake and retention of SQV in vivo in mice.

摘要

对诸如P-糖蛋白(P-gp)和多药耐药相关蛋白(Mrps)等外排转运体及其对沙奎那韦(SQV)脑摄取的贡献进行了表征。通过地西泮摄取估算脑血流量,并使用菊粉评估脑血管容积。用仅含SQV的缓冲液灌注小鼠脑,或与不同浓度的P-gp抑制剂GF120918或特定Mrp家族抑制剂MK571共同灌注。在所有研究中还共同灌注菊粉(一种不可吸收的标记物),以评估抑制剂是否改变血脑屏障(BBB)的物理完整性。用地西泮估算的脑血流量为250 ml·100g⁻¹·min⁻¹。在灌注研究期间,用菊粉估算的脑血管容积几乎恒定(0.94±0.03 ml·100 g⁻¹,n = 12)。在采样期间,SQV摄取动力学呈线性。灌注液中加入10 μM GF120918导致SQV的脑分布容积(即摄取)增加了7倍以上。灌注液中加入100 μM MK571使SQV的表观脑摄取增加了4.4倍以上,首次表明Mrp转运体可能在SQV的脑摄取和潴留中起重要作用。在研究过程中,GF120918和MK571均未改变BBB的完整性。尽管目前的结果再次证实SQV是P-gp的底物,但这是首次报道Mrp转运体家族在小鼠体内对SQV有限的脑摄取和潴留中的作用。

相似文献

1
P-glycoprotein and mutlidrug resistance-associated proteins limit the brain uptake of saquinavir in mice.P-糖蛋白和多药耐药相关蛋白限制了小鼠体内沙奎那韦的脑摄取。
J Pharmacol Exp Ther. 2005 Mar;312(3):1249-56. doi: 10.1124/jpet.104.076216. Epub 2004 Nov 4.
2
Human organic anion-transporting polypeptide OATP-A (SLC21A3) acts in concert with P-glycoprotein and multidrug resistance protein 2 in the vectorial transport of Saquinavir in Hep G2 cells.人类有机阴离子转运多肽OATP-A(SLC21A3)在庚型肝炎G2细胞中与P-糖蛋白和多药耐药蛋白2协同作用,参与沙奎那韦的向量转运。
Mol Pharm. 2004 Jan 12;1(1):49-56. doi: 10.1021/mp0340136.
3
Differential roles of P-glycoprotein, multidrug resistance-associated protein 2, and CYP3A on saquinavir oral absorption in Sprague-Dawley rats.P-糖蛋白、多药耐药相关蛋白2和CYP3A对沙奎那韦在Sprague-Dawley大鼠口服吸收中的不同作用。
Drug Metab Dispos. 2008 May;36(5):863-9. doi: 10.1124/dmd.107.017483. Epub 2008 Feb 6.
4
Interaction of dipeptide prodrugs of saquinavir with multidrug resistance protein-2 (MRP-2): evasion of MRP-2 mediated efflux.沙奎那韦二肽前药与多药耐药蛋白-2(MRP-2)的相互作用:规避MRP-2介导的外排。
Int J Pharm. 2008 Oct 1;362(1-2):44-51. doi: 10.1016/j.ijpharm.2008.06.013. Epub 2008 Jun 22.
5
The disposition of saquinavir in normal and P-glycoprotein deficient mice, rats, and in cultured cells.沙奎那韦在正常及P-糖蛋白缺陷的小鼠、大鼠和培养细胞中的处置情况。
Drug Metab Dispos. 2000 Sep;28(9):1058-62.
6
Differentiation of gut and hepatic first pass metabolism and secretion of saquinavir in ported rabbits.移植兔体内沙奎那韦的肠道和肝脏首过代谢及分泌的差异
J Pharmacol Exp Ther. 2004 Jul;310(1):359-66. doi: 10.1124/jpet.103.064394. Epub 2004 Mar 5.
7
Montelukast is a potent and durable inhibitor of multidrug resistance protein 2-mediated efflux of taxol and saquinavir.孟鲁司特是一种有效的、持久的多药耐药蛋白 2 介导的紫杉醇和沙奎那韦外排的抑制剂。
Biol Pharm Bull. 2009 Dec;32(12):2002-9. doi: 10.1248/bpb.32.2002.
8
Specific increase in MDR1 mediated drug-efflux in human brain endothelial cells following co-exposure to HIV-1 and saquinavir.人类脑内皮细胞在同时暴露于HIV-1和沙奎那韦后,多药耐药蛋白1(MDR1)介导的药物外排出现特异性增加。
PLoS One. 2013 Oct 3;8(10):e75374. doi: 10.1371/journal.pone.0075374. eCollection 2013.
9
Assessing safety and efficacy of directed P-glycoprotein inhibition to improve the pharmacokinetic properties of saquinavir coadministered with ritonavir.评估定向P-糖蛋白抑制作用以改善与利托那韦合用的沙奎那韦药代动力学特性的安全性和有效性。
J Pharmacol Exp Ther. 2003 Feb;304(2):596-602. doi: 10.1124/jpet.102.044388.
10
Modulation of the intracellular accumulation of saquinavir in peripheral blood mononuclear cells by inhibitors of MRP1, MRP2, P-gp and BCRP.MRP1、MRP2、P-糖蛋白和乳腺癌耐药蛋白抑制剂对外周血单核细胞中沙奎那韦细胞内蓄积的调节作用
AIDS. 2005 Dec 2;19(18):2097-102. doi: 10.1097/01.aids.0000194793.36175.40.

引用本文的文献

1
Investigating how HIV-1 antiretrovirals differentially behave as substrates and inhibitors of P-glycoprotein via molecular dynamics simulations.通过分子动力学模拟研究HIV-1抗逆转录病毒药物作为P-糖蛋白底物和抑制剂的不同行为。
Comput Struct Biotechnol J. 2024 Jun 21;23:2669-2679. doi: 10.1016/j.csbj.2024.06.025. eCollection 2024 Dec.
2
The role of membrane transporters in the absorption of atrazine following nasal exposure.鼻腔暴露后膜转运蛋白在阿特拉津吸收中的作用。
Inhal Toxicol. 2024 Apr;36(4):250-260. doi: 10.1080/08958378.2024.2348165. Epub 2024 May 13.
3
Nose to brain delivery of antiretroviral drugs in the treatment of neuroAIDS.
抗逆转录病毒药物经鼻至脑递送用于治疗神经艾滋病
Mol Biomed. 2020;1(1):15. doi: 10.1186/s43556-020-00019-8. Epub 2020 Dec 10.
4
Targeting Pathological Tau by Small Molecule Inhibition of the Poly(A):MSUT2 RNA-Protein Interaction.通过小分子抑制聚腺苷酸:MSUT2 RNA-蛋白质相互作用靶向病理性tau蛋白
ACS Chem Neurosci. 2020 Aug 5;11(15):2277-2285. doi: 10.1021/acschemneuro.0c00214. Epub 2020 Jul 9.
5
Tissue Physiology of Cynomolgus Monkeys: Cross-Species Comparison and Implications for Translational Pharmacology.食蟹猴组织生理学:种间比较及其对转化药理学的意义。
AAPS J. 2018 Oct 8;20(6):107. doi: 10.1208/s12248-018-0264-z.
6
Design and evaluation of a CXCR4 targeting peptide 4DV3 as an HIV entry inhibitor and a ligand for targeted drug delivery.设计和评价靶向 CXCR4 的肽 4DV3 作为 HIV 进入抑制剂和靶向药物递送配体。
Eur J Pharm Biopharm. 2019 May;138:11-22. doi: 10.1016/j.ejpb.2018.06.004. Epub 2018 Jun 9.
7
Nose-to-Brain Delivery of Antiviral Drugs: A Way to Overcome Their Active Efflux?抗病毒药物的鼻脑给药:克服其主动外排的一种方法?
Pharmaceutics. 2018 Mar 26;10(2):39. doi: 10.3390/pharmaceutics10020039.
8
Pharmacokinetic, Pharmacogenetic, and Other Factors Influencing CNS Penetration of Antiretrovirals.影响抗逆转录病毒药物中枢神经系统渗透的药代动力学、药物遗传学及其他因素
AIDS Res Treat. 2016;2016:2587094. doi: 10.1155/2016/2587094. Epub 2016 Sep 29.
9
Placental ABC Transporters: Biological Impact and Pharmaceutical Significance.胎盘 ABC 转运体:生物学影响与药物学意义。
Pharm Res. 2016 Dec;33(12):2847-2878. doi: 10.1007/s11095-016-2028-8. Epub 2016 Sep 19.
10
Getting into the brain: Potential of nanotechnology in the management of NeuroAIDS.进入大脑:纳米技术在神经艾滋病管理中的潜力。
Adv Drug Deliv Rev. 2016 Aug 1;103:202-217. doi: 10.1016/j.addr.2016.02.008. Epub 2016 Mar 2.